AAAAAA
Results:
1-20
|
Results: 20
Authors:
SHIMONO Y
HIGASHIGAWA M
NAGATA T
CAO DC
MAO XY
MSOKA T
INAMOCHI H
HORI H
KAWASAKI H
SAKURAI M
Citation: Y. Shimono et al., COMPARISON OF THE ACTIONS OF HYDROXYUREA AND 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE ON CYTOTOXICITY AND METABOLISM OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMAN T-CELL LEUKEMIA-CELL LINE MOLT-3, The Cancer journal, 11(5), 1998, pp. 247-253
Authors:
BONNO M
HIGASHIGAWA M
NAKANO T
MIYAHARA M
AZUMA E
KOMADA Y
ITO M
SAKURAI M
Citation: M. Bonno et al., ACUTE MYOSITIS WITH TRANSIENT DECREASE OF ALBUMIN, IMMUNOGLOBULIN, AND COMPLEMENT FOLLOWING ROTAVIRUS GASTROENTERITIS, Acta Paediatrica Japonica Overseas Edition, 40(1), 1998, pp. 82-84
Authors:
BONNO M
AZUMA E
KAWASAKI H
ZHANG XL
KOMADA Y
HIRAYAMA M
HIGASHIGAWA M
UMEMOTO M
KOIKE T
KATO T
TAHARA T
MIYAZAKI H
SAKURAI M
Citation: M. Bonno et al., THROMBOPOIETIN LEVEL IS INVERSELY RELATED TO BLAST COUNT, NOT PLATELET NUMBER, IN DOWN-SYNDROME NEONATES WITH TRANSIENT MYELOPROLIFERATIVE DISORDER, American journal of hematology, 58(4), 1998, pp. 267-272
Authors:
HIGASHIGAWA M
HORI H
HIRAYAMA M
KAWASAKI H
IDO M
AZUMA E
SAKURAI M
Citation: M. Higashigawa et al., SALVAGE THERAPY FOR RELAPSED OR REFRACTORY CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA BY ALTERNATIVE ADMINISTRATION A LYMPHOID-DIRECTED AND MYELOID-DIRECTED CHEMOTHERAPEUTIC REGIMEN CONSISTING OF DUAL MODULATION OF ARA-C HYDROXYUREA, AND ETOPOSIDE, Leukemia research, 21(9), 1997, pp. 811-815
Authors:
HIGASHIGAWA M
KOMADA Y
SHIMONO Y
NAGATA T
INAMOCHI H
MAO XY
MSOKA T
HORI H
KAWASAKI H
SAKURAI M
Citation: M. Higashigawa et al., FK506 INHIBITS ANTI-IGM ANTIBODY-INDUCED APOPTOSIS AND 17KD ENDONUCLEASE ACTIVITY IN THE HUMAN B-CELL LINE, MBC-1, ESTABLISHED FROM BURKITTS-LYMPHOMA, British Journal of Haematology, 99(4), 1997, pp. 908-913
Authors:
BONNO M
AZUMA E
KAWASAKI H
ZHANG XL
KOMADA Y
HIRAYAMA M
HIGASHIGAWA M
UMEMOTO M
KOIKE T
KATO T
TAHARA T
MIYAZAKI H
SAKURAI M
Citation: M. Bonno et al., THROMBOPOIETIN LEVEL IN PATIENTS WITH TRANSIENT MYELOPROLIFERATIVE DISORDER, Blood, 90(10), 1997, pp. 4058-4058
Authors:
HIGASHIGAWA M
KUWABARA H
CAO DC
HORI H
OHKUBO T
KAWASAKI H
IDO M
KOMADA Y
SAKURAI M
Citation: M. Higashigawa et al., HETEROGENEOUS EFFECTS OF G-CSF AND GM-CSF ON CELL-GROWTH AND ARA-C CYTOTOXICITY IN CHILDHOOD LEUKEMIAS WHICH EXPRESS MYELOID MARKERS, Leukemia & lymphoma, 22(3-4), 1996, pp. 279-285
Authors:
SUGA S
MIYAHARA M
OBATA M
HIGASHIGAWA M
ITO M
IHARA T
KAMIYA H
SHENG J
UEDA S
SAKURAI M
Citation: S. Suga et al., DETECTION BY POLYMERASE CHAIN-REACTION OF WILD-TYPE MEASLES-VIRUS GENOME IN THE CEREBROSPINAL-FLUID OF A PATIENT WITH SSPE WHO HAD RECEIVEDMEASLES-VACCINE, Clinical and diagnostic virology, 5(1), 1996, pp. 37-42
Authors:
OOI K
OHKUBO T
HIGASHIGAWA M
KAWASAKI H
SAKURAI M
Citation: K. Ooi et al., INCREASED DEOXYCYTIDINE KINASE-ACTIVITY BY ETOPOSIDE IN L1210 MURINE LEUKEMIC-CELLS, Biological & pharmaceutical bulletin, 19(10), 1996, pp. 1382-1383
Authors:
NOBUTOKI T
HORI H
HIGASHIGAWA M
AZUMA E
SAKURAI M
YOSHIZUMI T
NUNOUE T
Citation: T. Nobutoki et al., A CASE OF PROLONGED HUMAN PARVOVIRUS B19 DNA-EMIA ASSOCIATED WITH POLYCLONAL B-CELL ACTIVATION, Acta Paediatrica Japonica Overseas Edition, 38(4), 1996, pp. 348-351
Authors:
NAKANO T
SHIMONO Y
SUGIYAMA K
NISHIHARA H
HIGASHIGAWA M
KOMADA Y
ITO M
SAKURAI M
YOSHIDA A
KITAMURA K
IHARA T
KAMIYA H
HAMAZAKI M
SATA T
Citation: T. Nakano et al., CLINICAL-FEATURES OF MEASLES IN IMMUNOCOMPROMISED CHILDREN, Acta Paediatrica Japonica Overseas Edition, 38(3), 1996, pp. 212-217
Authors:
KAWASAKI H
SHINDOU K
HIGASHIGAWA M
CAO DC
HORI H
IDO M
SAKURAI M
Citation: H. Kawasaki et al., DEOXYCYTIDINE KINASE MESSENGER-RNA LEVELS IN LEUKEMIA-CELLS WITH COMPETITIVE POLYMERASE CHAIN-REACTION ASSAY, Leukemia research, 20(8), 1996, pp. 677-682
Authors:
NAGATA T
HIGASHIGAWA M
NAGAI M
ZHANG XL
AZUMA E
KOMADA Y
SAKURAI M
Citation: T. Nagata et al., A CHILD CASE OF CD34(-), HLA-DR(-), CD7(+), CD56(+) STEM-CELL LEUKEMIA WITH THYMIC INVOLVEMENT(), CD33(), Leukemia research, 20(11-12), 1996, pp. 983-985
Authors:
KAGAWA Y
OHKUBO T
HIGASHIGAWA M
IDO M
KAKITO H
INAGAKI S
KOJIMA M
OOI K
SAKURAI M
Citation: Y. Kagawa et al., EFFECTS OF UFT (MIXED COMPOUND OF TEGAFUR AND URACIL) ON CELL-KINETICS AND INHIBITION OF THYMIDYLATE SYNTHASE IN L1210 ASCITES TUMOR, Cancer investigation, 13(5), 1995, pp. 470-474
Authors:
SUGA S
TANAKA R
TABATA N
HIGASHIGAWA M
IDO M
AZUMA E
ITO M
SAKURAI M
Citation: S. Suga et al., SUCCESSFUL BONE-MARROW TRANSPLANTATION IN A CHILD WITH COMBINED IGG SUBCLASS DEFICIENCY AND NEUTROPENIA, Bone marrow transplantation, 16(6), 1995, pp. 847-848
Authors:
HIGASHIGAWA M
WATANABE M
NISHIHARA H
TABATA N
AZUMA E
IDO M
ITO M
SAKURAI M
Citation: M. Higashigawa et al., SUCCESSFUL TREATMENT OF AN INFANT WITH VENOOCCLUSIVE DISEASE DEVELOPED AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION BY TISSUE-PLASMINOGEN ACTIVATOR, HEPARIN AND PROSTAGLANDIN E(1), Leukemia research, 19(7), 1995, pp. 477-480
Authors:
KAWASAKI H
SHINDOU K
HIGASHIGAWA M
CAO D
HORI H
SAKURAI M
Citation: H. Kawasaki et al., DEOXYCYTIDINE KINASE MESSENGER-RNA AND ARA-CTP LEVEL IN LEUKEMIA-CELLS, Blood, 86(10), 1995, pp. 3048-3048
Authors:
HIGASHIGAWA M
CAO DC
MATSUI K
YAMADA S
KAKITOU H
KAGAWA Y
INAMOCHI H
IDO M
SAKURAI M
Citation: M. Higashigawa et al., COMBINED ORAL-ADMINISTRATION OF ETOPOSIDE AND ARABINOFURANOSYLCYTOSINE-5'-STEARYLPHOSPHATE ENHANCES THE ANTITUMOR EFFECT AGAINST P388 ASCITES TUMORS, Cancer chemotherapy and pharmacology, 33(4), 1994, pp. 281-285
Authors:
KAKITO H
OHKUBO T
KAGAWA Y
INAGAKI S
SUMIDA K
OOI K
HIGASHIGAWA M
SAKURAI M
Citation: H. Kakito et al., EFFECTS OF 5-FLUOROURACIL AND A COMBINATION OF TEGAFUR AND URACIL (UFT) ON NUCLEOTIDE-METABOLISM IN L1210 ASCITES TUMOR, Cancer investigation, 11(5), 1993, pp. 530-533
Authors:
OOI K
OHKUBO T
KUWABARA H
HIGASHIGAWA M
KAWASAKI H
KAKITOH H
KAGAWA Y
INAGAKI S
SUMIDA K
SAKURAI M
Citation: K. Ooi et al., ENHANCED INCORPORATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE BY PRETREATMENT WITH ETOPOSIDE, Cancer investigation, 11(4), 1993, pp. 388-392
Risultati:
1-20
|